Companies formed

Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.

Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.

The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

DiffBlue is a world leader in automated test generation. Their products have been developed with industry partners over the last ten years and replace the manual process of writing tests.

Incorporated in March 2016

Origin: Oxford University, Department of Computer Science

EKB Technology commercialises a revolutionary Bioprocessing Technology developed for the use of biological systems such as plant and animal cells and microorganisms to modify, produce or purify chemical intermediates.

Incorporated in December 2004

Origin: Oxford University, Department of Earth Sciences

EvOx Therapeutics harnesses the body’s own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.

Incorporated in April 2016

Origin: Oxford University, Neuroscience

G-Nostics has identified SNPs that have highly predictive associations with nicotine addiction and therefore tobacco consumption. These SNPs provide a method to help individuals decide which specific smoking cessation methods are most effective for them, offering personalised treatment to the 'smoker' which significantly increases their chances of quitting.

Incorporated in June 2004

Origin: Oxford University, Department of Pharmacology

Improving the lives of people living with Parkinson’s.

Incorporated in March 2020

Origin: Oxford University, Physiology, Anatomy and Genetics

Contact: Richard Auburn

Develop cutting edge software applications that uncover the relationships between genetic variation and human disease.
Help pharmaceutical companies de-risk the drug development process.

Incorporated in March 2014

Origin: Oxford University, Wellcome Trust Centre for Human Genetics

Campus supports sustainable, integrated and interuniversity learning opportunities, reinvesting profits in scholarships for students and/or building capacity in local heritage structures.

Incorporated in October 2020

Origin: Oxford University, International Development

Aim is to accelerate and streamline research through an innovative digital platform for knowledge sharing.

Incorporated in July 2020

Origin: Oxford University, Tropical Medicine

Malaria vaccine development.

Incorporated in September 2019

Origin: Oxford University, Jenner Institute

Glycosolation technology.

Incorporated in August 2002

Origin: Oxford University, Organic Chemistry

Developing international trade and transport simulators, using mathematical models and machine learning.

Incorporated in November 2020

Origin: Oxford University, Mathematical Institute

Contact: Adrian Coles

GryeOx addresses significant unmet need in drug discovery as the IP can make expanded drug libra of macrocycles in the hit to lead stage.

Incorporated in July 2019

Origin: Oxford University

Ready to get in touch?

Contact Us
© Oxford University Innovation